1. Home
  2. SWIM vs HQL Comparison

SWIM vs HQL Comparison

Compare SWIM & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Latham Group Inc.

SWIM

Latham Group Inc.

HOLD

Current Price

$6.42

Market Cap

838.8M

Sector

Industrials

ML Signal

HOLD

Logo abrdn Life Sciences Investors Shares of Beneficial Interest

HQL

abrdn Life Sciences Investors Shares of Beneficial Interest

HOLD

Current Price

$19.59

Market Cap

689.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWIM
HQL
Founded
1956
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Investment Managers
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
838.8M
689.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SWIM
HQL
Price
$6.42
$19.59
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$6.75
N/A
AVG Volume (30 Days)
739.2K
125.8K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
11.56%
EPS Growth
160.00
N/A
EPS
0.04
0.79
Revenue
$545,912,000.00
N/A
Revenue This Year
$10.95
N/A
Revenue Next Year
$6.34
N/A
P/E Ratio
$155.00
$24.56
Revenue Growth
7.35
N/A
52 Week Low
$4.64
$14.06
52 Week High
$8.97
$22.67

Technical Indicators

Market Signals
Indicator
SWIM
HQL
Relative Strength Index (RSI) 44.70 37.97
Support Level $6.19 $16.83
Resistance Level $6.79 $21.32
Average True Range (ATR) 0.31 0.46
MACD -0.07 -0.16
Stochastic Oscillator 32.14 14.98

Price Performance

Historical Comparison
SWIM
HQL

About SWIM Latham Group Inc.

Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. The company derives a majority of its revenue from the United States.

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.

Share on Social Networks: